Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to $1.1 million.

  • Rockwell Medical's Net Cash Flow rose 126.47% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 73.31%. This contributed to the annual value of $6.7 million for FY2024, which is 699.46% up from last year.
  • Per Rockwell Medical's latest filing, its Net Cash Flow stood at $1.1 million for Q3 2025, which was down 2.36% from $1.1 million recorded in Q2 2025.
  • Rockwell Medical's Net Cash Flow's 5-year high stood at $20.9 million during Q2 2022, with a 5-year trough of -$17.8 million in Q3 2022.
  • Over the past 3 years, Rockwell Medical's median Net Cash Flow value was $795,000 (recorded in 2023), while the average stood at $315,182.
  • As far as peak fluctuations go, Rockwell Medical's Net Cash Flow surged by 732.94% in 2022, and later slumped by 394.47% in 2024.
  • Over the past 5 years, Rockwell Medical's Net Cash Flow (Quarterly) stood at -$10.1 million in 2021, then skyrocketed by 71.53% to -$2.9 million in 2022, then spiked by 142.49% to $1.2 million in 2023, then surged by 171.87% to $3.3 million in 2024, then skyrocketed by 126.47% to $1.1 million in 2025.
  • Its Net Cash Flow was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and -$4.3 million in Q1 2025.